Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease

Iago Rodríguez–Lago, Javier del Hoyo, Alexandre Pérez‐Girbés, Alejandro Garrido‐Marín, María José Casanova, María Chaparro, A Fernández-Clotet, Jesús Castro‐Poceiro, María José García, Sara González Sánchez,

United European Gastroenterology Journal · 2020 · 44 citations · 18 references

DOIFull text

Open access

Abstract

Anti-TNF agents are effective in approximately a quarter of patients with Crohn's disease and symptomatic intestinal strictures, and 68% of patients are free of surgery after a median of 40 months of follow-up. Early treatment and some potential predictors of response were associated with treatment success in this setting.

References

18